400A – Studying cancer cachexia in mouse models
In 2011 Dr. Theresa Guise and her colleague Dr. Andrew Marks approached Aurora Scientific seeking help in functionally characterizing muscle from their mouse tumor model. They were looking to assess the progression of muscle loss and weakness in these mice and investigate potential therapies.
Because the pathology in these mice was incredibly aggressive, many animals would need to be tested in a short period of time. This would necessitate the use of multiple rigs and a robust transducer that allowed for high throughput. Because Dr. Guise was only looking to perform basic isometric strength and fatigue measures, a dual-mode lever system would have been prohibitively expensive for its capabilities.
Enter the Aurora Scientific 407A. As the transducer in the 400A series with the greatest force measurement capacity, it was suitable for making isometric force measurements in whole skeletal muscle from mouse. The unit is the most robust out of the whole 400A series, lessening the risk of accidental damage. The 407A was effectively paired with a modified 800A in-vitro muscle apparatus, as well as our 701C electrical stimulator and 615A DMC/DMA software.
The 407A transducer helped the labs of Dr. Guise and Dr. Marks to test many mouse models of cancer cachexia and performed so well that several more units were required in both labs to keep up with demand. Using the Aurora Scientific 407A, these researchers were ultimately able to determine the mechanisms and pathways that cause muscle weakness associated with various cancers. These results and many others were recently published in Nature Medicine.